M.D.C. (MDC) Stock Price, News & Analysis

Company Overview

M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, Washington, Colorado, Idaho, Utah, Alabama, Florida, Maryland, Pennsylvania, Tennessee, and Virginia. Its financial services operations comprise originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, Pennsylvania, and Virginia. The company was founded in 1972 and is headquartered in Denver, Colorado. As of April 19, 2024, M.D.C. Holdings, Inc. operates as a subsidiary of SH Residential Holdings, LLC.

Key Stats

• Today's Range: $62.98 to $62.98
• 50-Day Range: $62.62 to $62.98
• 52-Week Range: $36.47 to $63.00
• Volume: N/A
• Average Volume: 1.97 million shs
• Market Capitalization: $4.73 billion
• P/E Ratio: 11.93
• Dividend Yield: 3.49%
• Price Target: $63.00
• Consensus Rating: Hold

M.D.C. Stock Analysis - MarketRank™

M.D.C. scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

M.D.C. has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

M.D.C. has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of M.D.C. is 11.93, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.42.

Price to Earnings Ratio vs. Sector

The P/E ratio of M.D.C. is 11.93, which means that it is trading at a less expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 346.13.

Price to Book Value per Share Ratio

M.D.C. has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for MDC.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

M.D.C. pays a meaningful dividend of 3.49%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

M.D.C. does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of M.D.C. is 41.67%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for MDC.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: -0.38

News Coverage This Week

MarketBeat has tracked 7 news articles for M.D.C. this week, compared to 7 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, M.D.C. insiders have not sold or bought any company stock.

Percentage Held by Insiders

23.30% of the stock of M.D.C. is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

88.08% of the stock of M.D.C. is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MDC Stock Analysis - Frequently Asked Questions

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) announced its quarterly earnings results on Tuesday, January, 30th. The construction company reported $1.56 EPS for the quarter, beating analysts' consensus estimates of $1.50 by $0.06. M.D.C.'s revenue was down 11.9% on a year-over-year basis.

What other stocks do shareholders of M.D.C. own?

Based on aggregate information from My MarketBeat watchlists, some other companies that M.D.C. investors own include Chevron (CVX), Bristol-Myers Squibb (BMY), Comcast (CMCSA), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

• Last Earnings: 1/30/2024
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Cyclical
• Industry: Residential Construction
• Sub-Industry: Homebuilding
• Current Symbol: NYSE:MDC
• CUSIP: 55267610
• CIK: 773141
• Web: www.mdcholdings.com
• Phone: (303) 773-1100
• Fax: 303-771-3461
• Employees: 1,760
• Year Founded: 1972

Price Target and Rating

• Average Stock Price Target: $63.00
• High Stock Price Target: $63.00
• Low Stock Price Target: $63.00
• Potential Upside/Downside: +0.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $5.28
• Trailing P/E Ratio: 11.93
• Forward P/E Ratio: 11.05
• P/E Growth: N/A
• Net Income: $401.01 million
• Net Margins: 8.64%
• Pretax Margin: 11.33%
• Return on Equity: 12.32%
• Return on Assets: 7.34%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 9.76
• Quick Ratio: 3.92

Sales & Book Value

• Annual Sales: $4.64 billion
• Price / Sales: 1.02
• Cash Flow: $5.31 per share
• Price / Cash Flow: 11.85
• Book Value: $45.24 per share
• Price / Book: 1.39

Miscellaneous

• Outstanding Shares: 75,050,000
• Free Float: 57,562,000
• Market Cap: $4.73 billion
• Optionable: Optionable
• Beta: 1.54